FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094650757> ?p ?o ?g. }

• W3094650757 endingPage "333" @default.
• W3094650757 startingPage "325" @default.
• W3094650757 abstract "Efforts to improve buprenorphine access for opioid use disorder have focused on increasing the number of waivered providers. However, it is unknown how efforts to increase initial prescribing result in a sustained pool of prescribers. We examine the prevalence of year-to-year provider-level buprenorphine prescribing, and provider- and state-level factors associated with provider continuity.Providers prescribing buprenorphine/naloxone within the Medicare Part D claims database were evaluated from 2013 to 2017 with prescriber continuity measured as prescriptions made in consecutive years from the same provider (N = 14,222 unique providers; 6670 in 2013).The number of providers prescribing buprenorphine/naloxone within Medicare Part D increased from 2013 to 2017. The majority of providers prescribed buprenorphine/naloxone to 10 or fewer beneficiaries. Approximately 84% of providers prescribing buprenorphine/naloxone in 1 year prescribed it in the following year. Continuous prescribing from 2013 to 2017 was 59.4%, which was 86% the rate of a comparator chronic health medication (ie, lisinopril). Survival analyses indicated that female providers (adjusted hazard ratios [AHR] = 1.30, P < 0.001) and clinical neuroscience specialties such as psychiatry (AHR = 1.21, P < 0.001) exhibited greater discontinuation rates, whereas those with higher buprenorphine/naloxone beneficiary loads (AHR = 0.50, P < 0.001) and in states with a greater increase in overdose mortality rates (AHR = 0.88, P < 0.05) showed lower discontinuation rates.These data support evidence that providers who begin prescribing buprenorphine continue prescribing, although short of maximum capacity. Efforts to help providers become waivered, understand the impact of overdose fatalities in their area, and prescribe to multiple patients are likely to generate an enduring positive contribution to the number of treated patients." @default.
• W3094650757 created "2020-11-09" @default.
• W3094650757 creator A5017911936 @default.
• W3094650757 creator A5027917357 @default.
• W3094650757 creator A5032901243 @default.
• W3094650757 creator A5053588581 @default.
• W3094650757 creator A5082373948 @default.
• W3094650757 date "2020-11-03" @default.
• W3094650757 modified "2023-09-23" @default.
• W3094650757 title "Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D" @default.
• W3094650757 cites W1998453071 @default.
• W3094650757 cites W2010345632 @default.
• W3094650757 cites W2052138609 @default.
• W3094650757 cites W2089332158 @default.
• W3094650757 cites W2101931786 @default.
• W3094650757 cites W2138123339 @default.
• W3094650757 cites W2164822993 @default.
• W3094650757 cites W2496974376 @default.
• W3094650757 cites W2512344946 @default.
• W3094650757 cites W2598075248 @default.
• W3094650757 cites W2604462178 @default.
• W3094650757 cites W2606264631 @default.
• W3094650757 cites W2745737450 @default.
• W3094650757 cites W2760237777 @default.
• W3094650757 cites W2772268519 @default.
• W3094650757 cites W2802385597 @default.
• W3094650757 cites W2803411782 @default.
• W3094650757 cites W2808922973 @default.
• W3094650757 cites W2886531541 @default.
• W3094650757 cites W2890811699 @default.
• W3094650757 cites W2894104697 @default.
• W3094650757 cites W2896249325 @default.
• W3094650757 cites W2897233850 @default.
• W3094650757 cites W2912937853 @default.
• W3094650757 cites W2944267508 @default.
• W3094650757 cites W2955994854 @default.
• W3094650757 cites W2961500362 @default.
• W3094650757 cites W2969868507 @default.
• W3094650757 cites W2970774791 @default.
• W3094650757 cites W2983734219 @default.
• W3094650757 cites W2997506043 @default.
• W3094650757 cites W3000522174 @default.
• W3094650757 cites W3005454586 @default.
• W3094650757 doi "https://doi.org/10.1097/adm.0000000000000765" @default.
• W3094650757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33156180" @default.
• W3094650757 hasPublicationYear "2020" @default.
• W3094650757 type Work @default.
• W3094650757 sameAs 3094650757 @default.
• W3094650757 citedByCount "2" @default.
• W3094650757 countsByYear W30946507572022 @default.
• W3094650757 countsByYear W30946507572023 @default.
• W3094650757 crossrefType "journal-article" @default.
• W3094650757 hasAuthorship W3094650757A5017911936 @default.
• W3094650757 hasAuthorship W3094650757A5027917357 @default.
• W3094650757 hasAuthorship W3094650757A5032901243 @default.
• W3094650757 hasAuthorship W3094650757A5053588581 @default.
• W3094650757 hasAuthorship W3094650757A5082373948 @default.
• W3094650757 hasConcept C118552586 @default.
• W3094650757 hasConcept C126322002 @default.
• W3094650757 hasConcept C159110408 @default.
• W3094650757 hasConcept C170493617 @default.
• W3094650757 hasConcept C194828623 @default.
• W3094650757 hasConcept C2426938 @default.
• W3094650757 hasConcept C2777972943 @default.
• W3094650757 hasConcept C2778715236 @default.
• W3094650757 hasConcept C2778750930 @default.
• W3094650757 hasConcept C2778949969 @default.
• W3094650757 hasConcept C2779418921 @default.
• W3094650757 hasConcept C2781063702 @default.
• W3094650757 hasConcept C512399662 @default.
• W3094650757 hasConcept C71924100 @default.
• W3094650757 hasConceptScore W3094650757C118552586 @default.
• W3094650757 hasConceptScore W3094650757C126322002 @default.
• W3094650757 hasConceptScore W3094650757C159110408 @default.
• W3094650757 hasConceptScore W3094650757C170493617 @default.
• W3094650757 hasConceptScore W3094650757C194828623 @default.
• W3094650757 hasConceptScore W3094650757C2426938 @default.
• W3094650757 hasConceptScore W3094650757C2777972943 @default.
• W3094650757 hasConceptScore W3094650757C2778715236 @default.
• W3094650757 hasConceptScore W3094650757C2778750930 @default.
• W3094650757 hasConceptScore W3094650757C2778949969 @default.
• W3094650757 hasConceptScore W3094650757C2779418921 @default.
• W3094650757 hasConceptScore W3094650757C2781063702 @default.
• W3094650757 hasConceptScore W3094650757C512399662 @default.
• W3094650757 hasConceptScore W3094650757C71924100 @default.
• W3094650757 hasIssue "4" @default.
• W3094650757 hasLocation W30946507571 @default.
• W3094650757 hasLocation W30946507572 @default.
• W3094650757 hasOpenAccess W3094650757 @default.
• W3094650757 hasPrimaryLocation W30946507571 @default.
• W3094650757 hasRelatedWork W1992347686 @default.
• W3094650757 hasRelatedWork W2905124455 @default.
• W3094650757 hasRelatedWork W2944736729 @default.
• W3094650757 hasRelatedWork W2945035276 @default.
• W3094650757 hasRelatedWork W2976870114 @default.
• W3094650757 hasRelatedWork W3010234073 @default.
• W3094650757 hasRelatedWork W3165477506 @default.
• W3094650757 hasRelatedWork W3175080300 @default.

• next